Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Total 13F shares
-
5,967,794
-
Share change
-
-167,890
-
Total reported value
-
$46,727,000
-
Price per share
-
$7.83
-
Number of holders
-
35
-
Value change
-
-$1,774,036
-
Number of buys
-
13
-
Number of sells
-
16
Institutional Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2019
As of 30 Jun 2019,
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,967,794 shares.
The largest 10 holders included
Battery Partners IX, LLC, NEA Management Company, LLC, VANGUARD GROUP INC, CADENCE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, WELLS FARGO & COMPANY/MN, INGALLS & SNYDER LLC, PERKINS CAPITAL MANAGEMENT INC, and ESSEX INVESTMENT MANAGEMENT CO LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.